CAI FY 2020 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$294M-29.4% YoY

Gross Profit

$184M62.6% margin

Operating Income

$139M47.3% margin

Net Income

$28M9.4% margin

EPS (Diluted)

$1.55

Cash Flow

Operating Cash Flow

$277M

Free Cash Flow

$58M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$1.9B

Stockholders' Equity

$702M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$294M	$417M	-29.4%
Gross Profit	$184M	$201M	-8.2%
Operating Income	$139M	$130M	+6.8%
Net Income	$28M	$31M	-10.6%